Medical and Pharmaceutical Largest U.S. municipal healthcare system does over 10K lung cancer screenings since 2022 The achievement was announced as Lung Cancer Awareness Month begins Rowan DunneNovember 4, 2024
Medical and Pharmaceutical Ireland launches largest lung cancer research program to date This €4.9-million-euro initiative is being funded by the Irish Cancer Society Rowan DunneOctober 30, 2024
Medical and Pharmaceutical Can taking Aspirin reduce your risk of getting lung cancer? Some studies have indicated that it can, along with other cancers Rowan DunneOctober 17, 2024
Medical and Pharmaceutical Alpha Tau treats first lung cancer patient with radiation therapy in Jerusalem The Israeli company has used its proprietary Alpha DaRT treatment for other cancers but not lung Rowan DunneOctober 10, 2024
Medical and Pharmaceutical International Lung Cancer Consortium holds 20th annual meeting in Nashville The consortium is affiliated with the World Health Organization Rowan DunneOctober 7, 2024
Medical and Pharmaceutical Shattuck Labs plummets after dropping lead drug candidate; lays off 40% of workers The biotech company is giving up on a leukemia drug and shifting focus to a bowel disease treatment Rowan DunneOctober 1, 2024
Medical and Pharmaceutical Fertility solutions provider Progyny tanks after losing top client Progyny's termination by the unnamed client in January will result in a 13% loss of revenue, approximately Rowan DunneSeptember 19, 2024
Medical and Pharmaceutical From Kentucky to Nevada: $6.8M grant aims to spread lung cancer screening success Kentucky has more cases of lung cancer than any other state, but it has one of the highest screening rates Rowan DunneSeptember 19, 2024
AI and Autonomy AI capable of identifying lung cancer years before symptoms manifest Qure.ai just showcased the capabilities of its AI-powered chest X-ray at the World Conference on Lung Cancer Rowan DunneSeptember 11, 2024
Medical and Pharmaceutical AstraZeneca shares slide on disappointing lung cancer drug trial results "Dato-DXd" was thought to have immense potential but now appears to be a disappointment Rowan DunneSeptember 10, 2024